153 related articles for article (PubMed ID: 6543695)
1. Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry.
Giraldi T; Sava G; Cherubino R; Bottiroli G; Mazzini G
Clin Exp Metastasis; 1984; 2(2):151-9. PubMed ID: 6543695
[TBL] [Abstract][Full Text] [Related]
2. Antimetastatic action of some triazene derivatives against the Lewis lung carcinoma in mice.
Giraldi T; Houghton PJ; Taylor DM; Nisi C
Cancer Treat Rep; 1978 May; 62(5):721-5. PubMed ID: 657157
[TBL] [Abstract][Full Text] [Related]
3. Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma.
Giraldi T; Sava G; Mitri E; Cherubino R
Eur J Cancer Clin Oncol; 1984 Jul; 20(7):961-6. PubMed ID: 6540195
[TBL] [Abstract][Full Text] [Related]
4. Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential.
Sava G; Giraldi T; Zupi G; Sacchi A
Invasion Metastasis; 1984; 4(3):171-8. PubMed ID: 6480289
[TBL] [Abstract][Full Text] [Related]
5. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
[TBL] [Abstract][Full Text] [Related]
6. Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma.
Grill V; Mallardi F; Zorzet S; Perissin L; Giraldi T
Clin Exp Metastasis; 1987 Sep; 5(3):233-44. PubMed ID: 3652553
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma.
Ahmann DL; Edmonson JH; Frytak S; Kvols LK; Bisel HF; Rubin J
Cancer Treat Rep; 1978 Jan; 62(1):151-3. PubMed ID: 626995
[No Abstract] [Full Text] [Related]
8. Effects of dimethyltriazenes on in vitro Lewis lung carcinoma tumor lines with different metastatic capacity.
Zupi G; Corsi A; Sacchi A; Lassiani L; Giraldi T
Invasion Metastasis; 1984; 4(3):179-88. PubMed ID: 6480290
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.
Colombo T; D'Incalci M
Cancer Chemother Pharmacol; 1984; 13(2):139-41. PubMed ID: 6467499
[TBL] [Abstract][Full Text] [Related]
10. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
Sava G; Giraldi T; Lassiani L; Nisi C
Cancer Res; 1984 Jan; 44(1):64-8. PubMed ID: 6690062
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma.
Newlands ES; Oon CJ; Roberts JT; Elliott P; Mould RF; Topham C; Madden FJ; Newton KA; Westbury G
Br J Cancer; 1976 Aug; 34(2):174-9. PubMed ID: 962994
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma.
Sava G; Giraldi T; Nisi C; Bertoli G
Cancer Treat Rep; 1982 Jan; 66(1):115-20. PubMed ID: 7053247
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic activity of ICRF-159 combined with surgery: effects of postsurgical treatment with cyclophosphamide in mice bearing Lewis lung carcinoma lines.
Sava G; Zorzet S; Perissin L
Anticancer Res; 1985; 5(5):511-5. PubMed ID: 4062252
[TBL] [Abstract][Full Text] [Related]
14. Combination of radiation and razoxane (ICRF 159) in vivo.
Hellmann K; Grimshaw MB; Hutchinson GE
Int J Radiat Oncol Biol Phys; 1978; 4(1-2):109-13. PubMed ID: 632139
[No Abstract] [Full Text] [Related]
15. Stereoselective effects of cis- and trans-cyclopropylbis (dioxopiperazines) related to ICRF-159 on metastases of hamster lung adenocarcinoma.
Witiak DT; Lee HJ; Goldman HD; Zwilling BS
J Med Chem; 1978 Dec; 21(12):1194-7. PubMed ID: 722727
[TBL] [Abstract][Full Text] [Related]
16. Suppression of metastatic potential and up-regulation of gelatinases and uPA in LLC by protracted in vivo treatment with dacarbazine or razoxane.
Garbisa S; Onisto M; Peron A; Perissin L; Rapozzi V; Zorzet S; Giraldi T
Int J Cancer; 1997 Sep; 72(6):1056-61. PubMed ID: 9378540
[TBL] [Abstract][Full Text] [Related]
17. [Effects of bimolane on size, metastases and cyclic AMP levels of Lewis lung carcinoma].
Huang KW; Fu NW; Ren YF
Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):69-71. PubMed ID: 6326466
[No Abstract] [Full Text] [Related]
18. Effect of AT1727 on growth and metastasis of murine tumours.
Li XT; Hutchinson GE; Pym BA; Finch M; Hellmann K
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):283-7. PubMed ID: 6681774
[TBL] [Abstract][Full Text] [Related]
19. Lewis lung carcinoma lines with different metastatic behavior: response to ICRF-159.
Zupi G; Cavallari A; Greco C; Sacchi A
Anticancer Res; 1984; 4(1-2):91-5. PubMed ID: 6712181
[TBL] [Abstract][Full Text] [Related]
20. Infiltration of liver and brain by tumor cells in leukemic mice: prevention by dimethyltriazenes and cyclophosphamide.
Sava G; Giraldi T; Perissin L; Zorzet S; Mallardi F; Grill V
Tumori; 1984 Dec; 70(6):477-83. PubMed ID: 6531789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]